Browse by Day

Sunday | Monday | Tuesday | Wednesday

Tuesday, 7 December 2010

08:00 - 10:00

Plenary Session 1040: Asthma and endocrine co-morbidities
 Chairpersons: Abdulrahman Al Frayh, Waleed Al-Herz and Young Joo Cho
08:00 - 08:05
Welcoming Remarks
08:05 - 08:30
Dietary factors, obesity and pediatric asthma | Paul Greenberger (US)
08:30 - 08:55
Asthma and obesity in adults | Dennis Ledford (US)
08:55 - 09:20
Asthma and pregnancy | Harold Nelson (US)
09:20 - 09:45
Gender and development of asthma | Robert Lemanske (US)
09:45 - 10:00
Question & Answer

10:30 - 12:00

Symposium 1050: An overview of pediatric asthma
Chairpersons: Shereen Reda and Meenu Singh
10:30 - 10:35
Welcoming Remarks
10:35 - 10:55
Wheezing pre-asthma phenotypes in pre-school children | Robert Lemanske (US)
10:55 - 11:15
Asthma and allergies in school-age children and adolescents | Carlos E. Baena-Cagnani (Argentina)
11:15 - 11:35
Prevention of pediatric asthma and allergies | Tari Haahtela (Finland)
11:35 - 12:00
Discussion
Symposium 1051: Asthma, endocrine disorders and iatrogenesis
 Chairpersons: Motohiro Ebisawa and Lubna Hwejeh
10:30 - 10:35
Welcoming Remarks
10:35 - 10:55
Asthma treatment and the HPA axis | Paul Greenberger (US)
10:55 - 11:15
Asthma and endocrine disorders | Dennis Ledford (US)
11:15 - 11:35
Asthma co-morbidities in pregnancy | Sandra González-Díaz (Mexico)
11:35 - 12:00
Discussion
Symposium 1052: New concepts in severe asthma
 Chairpersons: Asma Al Nuaimi and Rabih Halwani
10:30 - 10:35
Welcoming Remarks
10:35 - 10:55
Asthma phenotypes: A clinically useful concept | Adnan Custovic (United Kingdom)
10:55 - 11:15
Defining and diagnosing severe asthma | Eric Bateman (South Africa)
11:15 - 11:35
Small airways disease in asthma | Stephen Peters (US)
11:35 - 12:00
Discussion

12:30 - 13:00

Keynote Lecture 1007: Use of antimicrobials to treat acute exacerbations of chronic bronchitis, asthma and COPD
 Chairperson: Mousa Khadadah　
12:30 - 12:35
Welcoming Remarks
12:35 - 13:00
Use of antimicrobials to treat acute exacerbations of chronic bronchitis, asthma and COPD | Eric Bateman (South Africa)

13:00 - 14:30

Symposium 1124: Sanofi-Aventis: Allergic airways diseases: From the evidence to clinical practice
Chairperson: Mario Sanchez-Borges
13:00 - 13:05
Welcoming Remarks
13:05 - 13:25
Burden of allergic diseases in Midle East countries | Faheem Tadros
13:25 - 13:45
From clinical evidence to real practice | Carlos E. Baena-Cagnani (Argentina)
13:45 - 14:05
Allergic airways diseases: Evidence based medicine | G. Walter Canonica (Italy)
14:05 - 14:20
Discussion

13:00 - 14:15

Abstract Posters 1120: Clinical immunology
 Chairpersons: Hani Ababneh and Lanny Rosenwasser
A rare case of ataxia telangiectasia in Malaysia
Bronchoalveolar lavage and serum eosinophil cationic protein levels in chronic asthma and bronchial carsinoma
Case report of relapsing polychondritis in children
Chronic eosinophilic pneumonia in patient with difficult-to-treat asthma
Clinical characteristics of eosinophilic organ involvement distinguishing from metastasis in cancer patients with eosinophilia
Expression of IL-17A and IL-17F cytokines in b lymphocytes
Opposite effect of etanercept and infliximab on the development of cutaneous vasculitis
PERIPHERAL eosinophilia
Study of IL-8 indices in elderly people with femoral neck fractures
Sulfated modification of lycium barbarum polysaccharide under microwave irradiation and their anti-HIV activities
The level of the tumor necrosis factor in patients with femoral neck fractures
Abstract Posters 1118: Drug and food allergy
 Chairpersons: Suleiman Al Hammadi and Sandra González-Díaz
Anaphylactic reaction induced by homeotoxic drug
Anaphylaxis after nasal provocation test with alternaria alternata extract
Anti-IgE antibody and food IgE-mediated diseases in severe asthmatic patients
Assessing potential determinants of positive provocation tests in subjects with NSAID hypersensitivity
Cisplatin administration following acute hypersensitivity to other platinum compounds: A phase II study
Clinical characteristics of ranitidine induced hypersensitivity
Cow milk sensitization in a group of egyptian allergic infants and children
Eczema induced by food allergy: Could it mimic an immune deficiency?
Effects of dietary counselling on protein intake and plasmatic protein profile in children with food allergy
Epidemiological study of food allergy in the town of constantine (Algeria)
Fixed drug eruption induced by ibuprofen and acetaminophen
Food allergy and atopic dermatitis
Frequency of immediate, late and delayed type food hypersensitivity in provocation test for egg allergy and its correlation with egg-white IgE RAST score
Interim findings from establishing the effectiveness, cost-effectiveness and safety of oral and sublingual immunotherapy for food allergy: A systematic review
Pangasius hypophthalmus hypersensitivity
Patient with peanut allergy with NEGATIVE cutaneous and IN VITRO TESTS, confirmed by ORAL CONTROLLED food challenge
Potential adverse reactions from complementary and alternative medicine (CAM) and dietary supplement (DS) in North America
The effectiveness of the measurement of total and specific IgE in diagnosis of cross allergy
The role of skin prick test in diagnosis of cross –allergy
Abstract Posters 1119: Skin and other diseases
 Chairpersons: Salem H. Al-Tamemi and Barbara Rogala
Anti-IgE (omalizumab) effective as single-drug therapy for chronic idiopathic urticaria
Comparative evaluation of epidemiological factors and complications of cataract surgery in diabetic patients versus non diabetic patients
Effect of a synbiotic mixture on atopic dermatitis in children: A randomized-controlled trial
Effectiveness of omalizumab in the treatment of cold urticaria
Efficacy of omalizumab monotherapy in the management of atopic dermatitis
Methotrexate for urticarial vasculitis and angioedema with cryoglobulinemia
Patient with vasculitic autoimmune and PRESSURE urticaria successfully treated with omalizuamb
The active form of d vitamin, calcitriol 1,25(OH)2D3 and natural PPRgamma agonist, -3 polyunsaturated fatty acids (PUFAs) might serve as a negative feedback loop to prevent excessive inflammation in patients with severe atopic dermatitis
Open-label use of Nanofiltered C1 Esterase Inhibitor (human) for Treatment or Prophylaxis of Acute Attacks of Hereditary Angioedema (HAE) in Pregnant Subjects
Open-label Use of Nanofiltered C1 Esterase Inhibitor (human) (nf-C1 INH) for the Prophylaxis of Attacks of Hereditary Angioedema (HAE) in Pediatric Subjects
Open-label use of Nanofiltered C1 Esterase Inhibitor (human) (nf-C1INH) for treatment of acute attacks of Hereditary Angioedema (HAE) in pediatric subjects
Open-Label Use of Nanofiltered C1 Esterase Inhibitor (Human) for the Prophylaxis of Hereditary Angioedema (HAE) Attacks
Open-label use of nanofiltered C1 esterase inhibitor (human) for the treatment of hereditary angioedema (HAE) attacks

14:30 - 16:30

Plenary Session 1043: Asthma and COPD: Present and future therapies
 Chairpersons: Karnen Baratawidjaja and Felicidad Cua-Lim
14:30 - 14:35
Welcoming Remarks
14:35 - 15:00
Novel therapies for asthma and COPD | Paul O'Byrne (Canada)
15:00 - 15:25
Future use of biologics in asthma and allergy | Lanny Rosenwasser (US)
15:25 - 15:50
Anti-IgE treatment in severe asthma | Thomas B. Casale (US)
15:50 - 16:15
Controversies in LABA | Stephen Peters (US)
16:15 - 16:30
Question & Answer

17:00 - 19:00

Symposium 1055: Asthma and COPD
 Chairpersons: Hasan Al-Dhekri and Kamal Hanna
17:00 - 17:05
Welcoming Remarks
17:05 - 17:25
Biomarkers in the assessment of asthma and COPD | Louis-Philippe Boulet (Canada)
17:25 - 17:45
Diagnosing and managing asthma and COPD | Neil Barnes
17:45 - 18:05
Smoking cessation | Riccardo Polosa (Italy)
18:05 - 18:25
Allergen avoidance strategies to reduce morbidity in asthma | Adnan Custovic (United Kingdom)
18:25 - 18:45
Discussion

17:00 - 18:30

Symposium 1053: Immunotherapy and immune modulators in asthma and allergic rhinitis
 Chairpersons: Ahmed Elbousify and Nagata Makoto
17:00 - 17:05
Welcoming Remarks
17:05 - 17:25
Subcutaneous immunotherapy | Harold Nelson (US)
17:25 - 17:45
Sublingual immunotherapy for patients with allergic rhinitis and asthma | G. Walter Canonica (Italy)
17:45 - 18:05
Novel strategies and future directions in immunotherapy | Glenis Scadding (United Kingdom)
18:05 - 18:30
Discussion
Symposium 1109: The multiple faces of asthma
Chairperson: Alessandro Fiocchi
17:00 - 17:20
The three dimensions of asthma: Asthma type, asthma severity and asthma personality | Jan Lötvall (Sweden)
17:20 - 17:40
Immunological mechanisms of asthma phenotypes | Christian Virchow (Germany)
17:40 - 18:00
Environmental influences on asthma and alllergy phenotypes | Omer Kalayci